The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
115451745 11545174 5 F 20160919 20150924 20160922 EXP US-PFIZER INC-2015311097 PFIZER 71.00 YR M Y 66.00000 KG 20160922 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
115451745 11545174 1 PS LYRICA PREGABALIN 1 Oral 150 MG, 1X/DAY D 21446 150 MG CAPSULE, HARD QD
115451745 11545174 2 SS LYRICA PREGABALIN 1 Oral 150 MG, 2X/DAY D L75538 21446 150 MG CAPSULE, HARD BID
115451745 11545174 3 SS LYRICA PREGABALIN 1 Oral 300 MG, 2X/DAY D M59942 21446 300 MG CAPSULE, HARD BID
115451745 11545174 4 SS LYRICA PREGABALIN 1 300 MG D M59942 21446 300 MG CAPSULE, HARD
115451745 11545174 5 C LABETALOL LABETALOLLABETALOL HYDROCHLORIDE 1 300 MG, 3X/DAY 0 300 MG TID
115451745 11545174 6 C HYDRALAZINE HYDRALAZINE HYDROCHLORIDE 1 25 MG, 3X/DAY 0 25 MG TID
115451745 11545174 7 C FOLIC ACID. FOLIC ACID 1 1 MG, 1X/DAY 0 1 MG QD
115451745 11545174 8 C MAGNESIUM OXIDE. MAGNESIUM OXIDE 1 400 MG, 1X/DAY 0 400 MG QD
115451745 11545174 9 C MEDROL METHYLPREDNISOLONE 1 4 MG, 1X/DAY 0 4 MG QD
115451745 11545174 10 C LEVOTHYROXINE. LEVOTHYROXINE 1 75 ?G, 1X/DAY 0 75 UG QD
115451745 11545174 11 C CYMBALTA DULOXETINE HYDROCHLORIDE 1 30 MG, 1X/DAY 0 30 MG CAPSULE QD
115451745 11545174 12 C ASPIRIN. ASPIRIN 1 81 MG, 1X/DAY 0 81 MG QD
115451745 11545174 13 C COLACE DOCUSATE SODIUM 1 100 MG, 2X/DAY 0 100 MG BID
115451745 11545174 14 C FLOMAX TAMSULOSIN HYDROCHLORIDE 1 0.8 MG, 1X/DAY (TWO TABLETS OF 0.4 MG) 0 .8 MG TABLET QD
115451745 11545174 15 C VITAMIN B12 CYANOCOBALAMIN 1 1000 ^GCM^, 1X/DAY 0 QD
115451745 11545174 16 C LIPITOR ATORVASTATIN CALCIUM 1 40 MG, 1X/DAY 0 40 MG QD
115451745 11545174 17 C SENNA SENNA LEAFSENNOSIDESSENNOSIDES A AND B 1 8.6 MG, 2X/DAY 0 8.6 MG BID
115451745 11545174 18 C ISOSORBIDE. ISOSORBIDE 1 10 MG, 3X/DAY 0 10 MG TID
115451745 11545174 19 C TACROLIMUS. TACROLIMUS 1 1 MG, 2X/DAY (ONE IN THE MORNING AND ONE IN THE EVENING) 0 1 MG TABLET BID
115451745 11545174 20 C NORVASC AMLODIPINE BESYLATE 1 10 MG, 1X/DAY 0 10 MG QD
115451745 11545174 21 C FERROUS SULFATE. FERROUS SULFATE 1 300/65 MG, 3X/DAY 0 1 DF TID
115451745 11545174 22 C CELLCEPT MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE 1 250 MG, 2X/DAY 0 250 MG BID
115451745 11545174 23 C LOSARTAN. LOSARTAN 1 25 MG, 1X/DAY 0 25 MG QD
115451745 11545174 24 C XANAX ALPRAZOLAM 1 1 MG THREE TABLETS AS NEEDED EVERY 6 HOURS 0 3 MG TABLET
115451745 11545174 25 C CRANBERRY. CRANBERRY 1 1 DF, 1X/DAY 0 1 DF CAPSULE QD
115451745 11545174 26 C SODIUM BICARBONATE. SODIUM BICARBONATE 1 650 MG, 1X/DAY 0 650 MG QD
115451745 11545174 27 C OMEPRAZOLE. OMEPRAZOLE 1 20 MG, 1X/DAY 0 20 MG QD
115451745 11545174 28 C LANTUS INSULIN GLARGINE 1 25 IU, 1X/DAY (TAKES ON A SLIDING SCALE UP TO 25 UNITS A DAY IN THE EVENING) 0 25 IU QD
115451745 11545174 29 C HUMALOG INSULIN LISPRO 1 A SLIDING SCALE BEFORE MEALS FOUR TIMES DAILY 0 QID
115451745 11545174 30 C PLAVIX CLOPIDOGREL BISULFATE 1 75 MG, 1X/DAY 0 75 MG QD
115451745 11545174 31 C CILOSTAZOL. CILOSTAZOL 1 100 MG, HALF IN THE MORNING AND HALF IN THE EVENING 0 50 MG TABLET BID
115451745 11545174 32 C NITROSTAT NITROGLYCERIN 1 Sublingual 0.4 MG, AS NEEDED 0 .4 MG
115451745 11545174 33 C RANEXA RANOLAZINE 1 500 MG, 2X/DAY 0 500 MG BID
115451745 11545174 34 C HYDROCODONE HYDROCODONE 1 10-325 EVERY 6 HOURS AS NEEDED 0
115451745 11545174 35 C HYDROCODONE HYDROCODONE 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
115451745 11545174 1 Neuropathy peripheral
115451745 11545174 2 Psoriatic arthropathy
115451745 11545174 3 Pain
115451745 11545174 11 Depression
115451745 11545174 30 Anticoagulant therapy
115451745 11545174 32 Angina pectoris
115451745 11545174 34 Psoriasis
115451745 11545174 35 Neuropathy peripheral

Outcome of event

Event ID CASEID OUTC COD
115451745 11545174 OT
115451745 11545174 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
115451745 11545174 Arteriosclerosis coronary artery
115451745 11545174 Arthralgia
115451745 11545174 Balance disorder
115451745 11545174 Calcinosis
115451745 11545174 Drug ineffective
115451745 11545174 Feeling abnormal
115451745 11545174 Influenza
115451745 11545174 Malaise
115451745 11545174 Nasal congestion
115451745 11545174 Nasopharyngitis
115451745 11545174 Pain
115451745 11545174 Pain in extremity
115451745 11545174 Pancreatic insufficiency
115451745 11545174 Psoriatic arthropathy
115451745 11545174 Pyrexia
115451745 11545174 Renal failure
115451745 11545174 Renal vascular thrombosis
115451745 11545174 Transplant failure

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found